Xenon Pharmaceuticals IncNASDAQ:XENE
- LAST PRICE43.4300
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 43.4300
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | XENE |
|---|---|---|
| 09:32 ET | 1233 | 43.345 |
| 09:34 ET | 200 | 43.22 |
| 09:36 ET | 100 | 43.15 |
| 09:38 ET | 100 | 42.95 |
| 09:39 ET | 204 | 42.83 |
| 09:41 ET | 300 | 42.955 |
| 09:43 ET | 100 | 42.935 |
| 09:45 ET | 469 | 42.955 |
| 09:48 ET | 689 | 42.995 |
| 09:50 ET | 900 | 42.925 |
| 09:52 ET | 3056 | 42.835 |
| 09:57 ET | 200 | 42.96 |
| 10:01 ET | 100 | 42.83 |
| 10:03 ET | 291 | 42.83 |
| 10:06 ET | 200 | 42.82 |
| 10:08 ET | 100 | 42.895 |
| 10:10 ET | 100 | 42.91 |
| 10:14 ET | 100 | 42.86 |
| 10:15 ET | 100 | 42.82 |
| 10:17 ET | 200 | 42.88 |
| 10:19 ET | 200 | 42.95 |
| 10:32 ET | 300 | 42.79 |
| 10:33 ET | 200 | 42.7625 |
| 10:35 ET | 100 | 42.645 |
| 10:39 ET | 700 | 42.78 |
| 10:42 ET | 100 | 42.815 |
| 10:44 ET | 300 | 42.74 |
| 10:48 ET | 100 | 42.78 |
| 10:50 ET | 100 | 42.815 |
| 10:53 ET | 100 | 42.875 |
| 10:55 ET | 7349 | 43.15 |
| 10:57 ET | 279 | 43.23 |
| 11:00 ET | 400 | 43.21 |
| 11:02 ET | 400 | 43.145 |
| 11:04 ET | 2908 | 43.26 |
| 11:06 ET | 1277 | 43.2899 |
| 11:08 ET | 1337 | 43.3 |
| 11:09 ET | 771 | 43.07 |
| 11:22 ET | 100 | 43.22 |
| 11:26 ET | 100 | 43.08 |
| 11:29 ET | 400 | 43.25 |
| 11:33 ET | 100 | 43.21 |
| 11:45 ET | 200 | 43.19 |
| 12:16 ET | 200 | 43.08 |
| 12:20 ET | 400 | 43.08 |
| 12:34 ET | 700 | 43.12 |
| 12:39 ET | 200 | 43.15 |
| 12:43 ET | 100 | 43.22 |
| 12:45 ET | 100 | 43.29 |
| 12:50 ET | 400 | 43.26 |
| 12:52 ET | 100 | 43.215 |
| 12:59 ET | 100 | 43.21 |
| 01:01 ET | 100 | 43.17 |
| 01:03 ET | 336 | 43.31 |
| 01:12 ET | 300 | 43.21 |
| 01:14 ET | 100 | 43.19 |
| 01:17 ET | 100 | 43.24 |
| 01:39 ET | 200 | 43.12 |
| 01:42 ET | 300 | 43.095 |
| 01:44 ET | 200 | 43.08 |
| 01:46 ET | 100 | 43.1 |
| 01:50 ET | 200 | 43.09 |
| 01:57 ET | 900 | 43.16 |
| 02:09 ET | 400 | 43.14 |
| 02:24 ET | 1000 | 43.08 |
| 02:31 ET | 205 | 43.13 |
| 02:33 ET | 400 | 43.03 |
| 02:38 ET | 500 | 42.965 |
| 02:49 ET | 100 | 42.955 |
| 02:51 ET | 203 | 42.99 |
| 02:56 ET | 600 | 43.05 |
| 02:58 ET | 300 | 43.08 |
| 03:02 ET | 100 | 43.11 |
| 03:03 ET | 100 | 43.145 |
| 03:05 ET | 200 | 43.15 |
| 03:07 ET | 200 | 43.16 |
| 03:09 ET | 100 | 43.19 |
| 03:12 ET | 1011 | 43.16 |
| 03:20 ET | 100 | 43.12 |
| 03:23 ET | 200 | 43.21 |
| 03:25 ET | 203 | 43.31 |
| 03:27 ET | 399 | 43.29 |
| 03:36 ET | 100 | 43.34 |
| 03:39 ET | 500 | 43.38 |
| 03:41 ET | 2124 | 43.31 |
| 03:43 ET | 100 | 43.34 |
| 03:45 ET | 530 | 43.37 |
| 03:48 ET | 364 | 43.3552 |
| 03:50 ET | 1820 | 43.44 |
| 03:52 ET | 2213 | 43.51 |
| 03:54 ET | 2053 | 43.57 |
| 03:56 ET | 4173 | 43.48 |
| 03:57 ET | 3755 | 43.44 |
| 03:59 ET | 5440 | 43.43 |
Yesterday
May 2, 2024
Apr 16, 2024
Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting, from 8:30AM ET on Tuesday Apr 16, 2024 by Dow Jones
8:30AM ET on Tuesday Apr 16, 2024 by Dow Jones
Apr 12, 2024
DJ Xenon Pharmaceuticals Price Target Maintained With a $62.00/Share by Needham, from 7:13AM ET on Friday Apr 12, 2024 by Dow Jones
7:13AM ET on Friday Apr 12, 2024 by Dow Jones
Apr 10, 2024
DJ Xenon Pharmaceuticals Price Target Maintained With a $65.00/Share by Cantor Fitzgerald, from 9:57AM ET on Wednesday Apr 10, 2024 by Dow Jones
9:57AM ET on Wednesday Apr 10, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Xenon Pharmaceuticals Inc | 3.3B | -15.9x | --- |
Janux Therapeutics Inc | 3.2B | -50.2x | --- |
Summit Therapeutics Inc | 3.1B | -3.5x | --- |
IDEAYA Biosciences Inc | 3.2B | -21.4x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Apogee Therapeutics Inc | 3.1B | -30.1x | --- |
Company Information
Xenon Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company focused on developing therapeutics to improve the lives of patients with neurological disorders, with a focus on epilepsy. The Company’s product pipeline includes XEN1101 (Focal Onset Seizures), XEN1101 (Primary Generalized Tonic-Clonic Seizures), XEN1101 (Major Depressive Disorder) and NBI-921352 (NEUROCRINE). It is developing XEN1101, a differentiated Kv7 potassium channel opener, for the treatment of epilepsy, MDD and potentially other neurological disorders. Its XEN1101 Phase III epilepsy program includes two identical Phase III clinical trials, called X-TOLE2 and X-TOLE3, that are designed closely after the Phase IIb X-TOLE clinical trial. Its Phase III X-ACKT clinical trial is intended to support potential regulatory submissions in an additional epilepsy indication of primary generalized tonic-clonic seizures (PGTCS).
Contact Information
- Headquarters
- 3650 Gilmore WayVANCOUVER, BC, Canada V5G 4W8
- Phone
- 604-484-3300
- Fax
- 604-484-3450
Executives
- Chairman of the Board
- Simon Pimstone
- President, Chief Executive Officer, Director
- Ian Mortimer
- Chief Financial Officer
- Sherry Aulin
- Executive Vice President - Drug Discovery
- James Empfield
- Executive Vice President - Strategy and Innovation
- Robin Sherrington
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.3B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 75.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.26 |
EPS | $-2.73 |
Book Value | $12.31 |
P/E Ratio | -15.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
